Tempe, AZ, United States of America

Kartik Temburnikar

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: University System of Maryland. Active years: 2016-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kartik Temburnikar. Retrieved from https://idiyas.com/inventor/kartik-temburnikar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kartik Temburnikar: Innovator in Anticancer Research

Introduction

Kartik Temburnikar is a notable inventor based in Tempe, AZ (US). He has made significant contributions to the field of cancer research through his innovative work. With a total of 3 patents, Temburnikar is recognized for his dedication to developing effective treatments for cancer.

Latest Patents

Temburnikar's latest patents include the design and synthesis of halogenated thieno- and pyrrolopyrimidine analogues as anticancer agents. These compounds exhibit cancer proliferation inhibitory activity and are aimed at improving cancer treatment methods. His work focuses on the potential of these compounds to provide new avenues for combating cancer.

Career Highlights

Kartik Temburnikar is affiliated with the University System of Maryland, where he continues to advance his research in the field of oncology. His innovative approach and commitment to scientific discovery have positioned him as a key figure in cancer research.

Collaborations

Temburnikar collaborates with Katherine L Radtke, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Kartik Temburnikar's contributions to anticancer research through his patents and collaborations highlight his role as an influential inventor in the scientific community. His work continues to inspire advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…